Latest Conference Articles

Analysis of cancer surveillance, insurance coverage, and household income data indicates that thyroid cancer rates are positively correlated with higher rates of insurance coverage and higher income.

For properly selected patients with small PTC nodules active surveillance is a viable management option associated with a very low rate of short-term progression

Study results indicate that diabetes mellitus is independently associated with the development of cirrhosis and hepatocellular carcinoma among patients who have fatty liver disease.

Results from a clinical trial designed to evaluate the effectiveness of a hepatitis C educational program delivered by the Hepatology Centers of Educational Expertise, a hepatologist-led working group dedicated to educating healthcare professionals on the latest developments in the management of chronic liver disease.

Case study results indicate boceprevir-based triple therapy could be a viable treatment option for patients with acute hepatitis C virus who fail to respond to standard treatment.

Study results show that patients currently taking opioids and those who were previously on chronic opioid therapy experienced induced esophageal dysfunction, with outflow obstruction and spastic esophageal dysmotility patterns more prevalent among current users.

Researchers report a cure rate of greater than 90 percent among patients with recurrent C. difficile infection treated with fecal microbiota transplantation at a community hospital.

Study results show that improvement in short-term mortality was seen in patients who receive corticosteroids for treatment of severe alcoholic hepatitis without an increased risk of infection occurrence.

Patients with advanced Alzheimer's disease treated with 13.3 mg rivastigmine patch showed greater improvements in cognitive, functional, and behavioral performance from baseline compared to patients who received 4.6 mg patches.

Despite current guideline recommendations against the use of routine neuroimaging for uncomplicated headaches, physicians still tend to order imaging tests for many patients who present with headache and migraine, driving up annual healthcare spending.

Study results show that patients who received combination treatment demonstrated improvements in cognition, function, and behavioral outcomes compared to treatment with either medication alone or placebo.

Five-day conference showcases up-to-date research and clinical advances in a wide range of thyroid-related diseases and conditions.

Patients with advanced Parkinson's disease treated with an investigational extended-release carbidopa-levodopa formulation experienced greater reductions in "off" time and greater improvement in dyskinesia-free "on" time compared with similar patients treated with carbidopa-levodopa plus entacapone.

Results from the first multi-center interventional trial in premanifest HD research show that the antioxidant Coenzyme Q10 is associated with only mild or moderate side effects, even at higher doses.

Study results indicate a significant correlation between depression and hallucination in patients with Parkinson's disease, while anxiety is a significant predictor for both the number and severity of hallucinations.

A large majority of patients with chronic hepatitis C cleared their virus after receiving triple therapy of pegylated interferon, ribavirin, and boceprevir for 24 weeks. No patients in the study cohort discontinued treatment due to medication-related side effects.

Study results show that SIRS on admission and at 72 hours after is associated with a higher incidence of pancreatic necrosis, an important risk factor contributing to death in patients with severe acute pancreatitis.

A literature search found no well-documented evidence showing that implementing a gluten-and-casein-free diet in children with autism produces statistically significant differences in autism-related behaviors.

Two studies at the American College of Gastroenterology's 78th Annual Scientific Meeting analyzed the health outcomes of inflammatory bowel disease in the U.S. and Canada.

Study shows that the use of telemedicine by primary stroke centers and other hospitals increases access to specialized stroke care for patients living in rural and medically underserved areas.

Study results show that a structured educational intervention for staff aimed at improving knowledge of pain assessment and treatment has little effect on outcomes as measured by pain scores.

Correlation between change in brain volume and a clinical measure of cognitive function could be potential marker for clinical progression of multiple sclerosis.

Long-term usage of crofelemer, a drug that relieves noninfectious diarrhea symptoms in patients with HIV, was well-tolerated and produced few adverse events in a recent study.

Although fecal microbial transplant is highly effective in treating recurrent C. difficile infection, a survey of infectious disease specialists shows that several barriers prevent the treatment from being available at most institutions.

Study results show that daptomycin cleared MRSA infections within four days of treatment in 80% of patients and was particularly effective against extra-vascular infections.

Researchers suggest that monitoring for the loss of CD62L expression on CD4+ T cells is a biomarker for risk assessment in patients treated with natalizumab who may develop PML, since other treatments do not show this pattern of C62L loss of expression.

Late-breaking study results reported at ECTRIMS 2013 indicate that neurofilament levels may be reliable biomarkers of nerve damage and disease progression in patients with relapsing multiple sclerosis.

Study results show that treatment with riluzole did not slow the rate of brain atrophy and did not demonstrate a detectable neuroprotective effect in patients with early RRMS.

Patients treated with oromucosal nabiximols spray experienced up to 30% reduction in spasticity, as measured by a numerical rating scale, after 12 months of treatment.

Nonadherence is highest in patients undergoing treatment with subcutaneous or intramuscular injection formulations of DMT.